Mail & Guardian
Mail & Guardian
tumourslatest news & developments
In some trials two new approaches have eliminated all traces of blood cancers in 40% to 90% of patients who had no remaining options.
BHEKISISA TEAM

Experimental cancer drugs effective – but with drawbacks

Two emerging technologies look promising, but top oncology researchers are concerned about dangers seen during clinical trials.

  • Bhekisisa Team
6 min read